Loading…
Carlsmed, Inc. is projected to rise to $14.07 by 2027, a +12% move from its current price of $12.59. CARL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $12.12 | $12.59 | $13.08 | +0.01% |
| Aug 4 | $11.94 | $12.59 | $13.28 | +0.01% |
| Aug 5 | $11.79 | $12.59 | $13.45 | +0.02% |
| Aug 6 | $11.67 | $12.59 | $13.58 | +0.03% |
| Aug 7 | $11.57 | $12.59 | $13.71 | +0.04% |
| Aug 8 | $11.48 | $12.60 | $13.82 | +0.04% |
| Aug 9 | $11.40 | $12.60 | $13.92 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $11.40 | $12.60 | $13.92 | +0.05% |
| Week 2 | $10.94 | $12.60 | $14.52 | +0.10% |
| Week 3 | $10.60 | $12.61 | $15.00 | +0.15% |
| Week 4 | $10.32 | $12.62 | $15.41 | +0.20% |
| Week 5 | $10.09 | $12.62 | $15.79 | +0.25% |
| Week 6 | $9.88 | $12.63 | $16.14 | +0.30% |
| Week 7 | $9.69 | $12.63 | $16.47 | +0.35% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Carlsmed, Inc. is a commercial-stage medical technology company that designs, manufactures, and markets AI-enabled personalized spine surgery solutions.
Its aprevo platform includes proprietary surgical planning software using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants.
The company was incorporated in 2018 and is based in Carlsbad, California.
Carlsmed, Inc. (CARL) is currently priced at $12.31, reflecting its latest level in the market. The stock trades within a healthcare-focused sector, offering investors exposure to AI-enabled spine surgery solutions.
The company has a market capitalization of $334.65M and is ranked 3244 by market cap size. This places it among smaller-cap healthcare equities with growth-oriented potential.
Near term, the forecast shows neutral sentiment through 2026 to 2029, with bullish potential emerging from 2030 onward as average price projections rise across the period. The long-range view indicates substantial upside, culminating in a higher average price by 2050.
A major floor 30.1% below — a decisive break under it would weaken the trend.
The nearest floor, 21.8% below — buyers have tended to step in here.
Price is pressing into resistance (1.5% away) — a breakout level to watch.
A major ceiling 16.6% above — clearing it would confirm fresh momentum.
Key CARL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CARL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $12.36 | Buy | $12.33 | Buy |
| MA 10 | $11.74 | Buy | $12.02 | Buy |
| MA 20 | $11.80 | Buy | $11.76 | Buy |
| MA 50 | $11.41 | Buy | $11.40 | Buy |
| MA 100 | $10.81 | Buy | $11.36 | Buy |
| MA 200 | $11.89 | Buy | $11.84 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.14 | Neutral |
| Stoch RSI (14) | 87.60 | Sell |
| CCI (20) | 94.86 | Neutral |
| Williams %R (14) | -9.60 | Info |
| MACD (12,26,9) | 0.12 | Buy |
| ROC (12) | 13.63 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 90.40 | Sell |
| TRIX (15) | 0.20 | Buy |
| Awesome (5,34) | 0.94 | Buy |
| Ultimate (7,14,28) | 71.43 | Sell |
| Momentum (10) | 0.93 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 13.04 | Sell |
| ADX (14) | 11.59 | Neutral |
| ATR (14) | 0.40 | Info |
The 30-day technical picture is neutral, with sentiment labeled NEUTRAL and RSI(14) at 50. This suggests a balanced short-term stance without overbought or oversold pressure.
Near-term price levels show a 30-day range from $9.51 to $15.93, helping define support and resistance boundaries. The 50-day simple moving average sits at $11.28, slightly below the 200-day SMA of $11.92, indicating a cautious trend with limited momentum.
Key support sits at $9.84 and resistance at $12.57, framing potential trading ranges around the current level of $12.31.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.83 | $12.59 | $15.58 | 0% | Neutral | |
| $10.41 | $14.07 | $20.51 | +12% | Neutral | |
| $9.94 | $14.20 | $21.99 | +13% | Neutral | |
| $10.65 | $15.96 | $25.89 | +27% | Bullish | |
| $13.56 | $21.19 | $35.71 | +68% | Bullish | |
| $14.82 | $24.09 | $41.97 | +91% | Bullish | |
| $16.74 | $28.24 | $50.66 | +124% | Bullish | |
| $17.10 | $29.89 | $55.04 | +137% | Bullish | |
| $15.31 | $27.71 | $52.26 | +120% | Bullish | |
| $16.34 | $30.58 | $58.94 | +143% | Bullish | |
| $24.22 | $53.29 | $112.43 | +323% | Bullish | |
| $46.53 | $103.40 | $237.83 | +721% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $8.83 | $12.59 | $15.19 | +0.00% |
| September 2026 | $10.42 | $12.62 | $15.91 | +0.22% |
| October 2026 | $10.33 | $12.67 | $16.28 | +0.43% |
| November 2026 | $9.72 | $12.04 | $15.70 | -4.99% |
| December 2026 | $9.43 | $11.80 | $15.58 | -2.03% |
Click any year to see its month-by-month CARL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CARL price prediction for 2026 points to an average of $12.59 (low $8.83, high $15.58) — a potential gain of 0% on today's $12.59. A consolidation phase looks the most probable path here.
In 2027, CARL is projected to trade between $10.41 and $20.51, averaging $14.07 — a potential gain of +12% from today's $12.59. That is up +12% on the projected 2026 average. Price action looks broadly range-bound.
Carlsmed, Inc.'s 2028 outlook centres on $14.20, within a $9.94 to $21.99 range. That is up +1% on the projected 2027 average. That marks a +13% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, CARL could reach as high as $25.89, with a base case around $15.96 and support toward $10.65 — roughly +27% from $12.59. Momentum favours further upside here.
Expect CARL to range from $13.56 to $35.71 through 2030. The $21.19 average target implies a +68% move from current prices. That is up +33% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The CARL price prediction for 2031 points to an average of $24.09 (low $14.82, high $41.97) — a potential gain of +91% on today's $12.59. Momentum favours further upside here.
In 2032, CARL is projected to trade between $16.74 and $50.66, averaging $28.24 — a potential gain of +124% from today's $12.59. That is up +17% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Carlsmed, Inc.'s 2033 outlook centres on $29.89, within a $17.10 to $55.04 range. That is up +6% on the projected 2032 average. That marks a +137% change versus current levels. Momentum favours further upside here.
By 2034, CARL could reach as high as $52.26, with a base case around $27.71 and support toward $15.31 — roughly +120% from $12.59. Buyers look set to stay in control over this stretch.
Expect CARL to range from $16.34 to $58.94 through 2035. The $30.58 average target implies a +143% move from current prices. That is up +10% on the projected 2034 average. Momentum favours further upside here.
The CARL price prediction for 2040 points to an average of $53.29 (low $24.22, high $112.43) — a potential gain of +323% on today's $12.59. Buyers look set to stay in control over this stretch.
In 2050, CARL is projected to trade between $46.53 and $237.83, averaging $103.40 — a potential gain of +721% from today's $12.59. That is up +94% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CARL today (≈ 79.428118 CARL) could be worth
$8,213.1
+$7,213.1 (+721%) by 2050 · US Dollar
Based on the average projected CARL price of $103.4 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CARLwould be worth at today's price.
$1,000 invested in CARL on Jul 31, 2025 (≈ 71.123753 CARL) would be worth
$895.45
-$104.55 (-10.5%) today · 0.90× · US Dollar
Based on a CARL entry price of $14.06 vs. today's $12.59.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.8 | $1,165.74 | +16.6% |
| 1 month ago | $11.71 | $1,075.15 | +7.5% |
| 3 months ago | $9.48 | $1,328.06 | +32.8% |
| 6 months ago | $12.46 | $1,010.43 | +1.0% |
| 1 year ago | $14.06 | $895.45 | -10.5% |
| All time (1.0y) ago | $14.5 | $868.28 | -13.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CARL forecast.
Our base-case forecast reaches $25.00 around 2032.
Implied market cap at $25.00: $679.62M
The multi-year forecast shows a forward path from neutral to bullish as the years unfold. In 2030 the average price is projected to $17.08, with a min of $10.75 and a max of $29.19, and an estimated ROI of 38.7% in a bullish setting.
By 2031 the average rises to $19.23, with a max of $34.01 and ROI of 56.3%, continuing the bullish trajectory. The 2032 forecast shows an average of $22.59 with a max of $41.16 and ROI of 83.5%, followed by 2033 at an average of $23.37 and max of $43.74 with ROI 89.9%.
In 2040 the average is projected to $37.52 and the max to $80.74, with a significant ROI of 204.8%. By 2050 the average reaches $66.37 and the max $152.66, with ROI expanding to 439.2% in a strongly bullish outlook.
These figures illustrate a substantial upside from the 2026 baseline, though they remain estimates and are not guarantees. The results reflect scheduled forecasted paths across years, highlighting potential long-range appreciation.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $17.08, a min of $10.75 and a max of $29.19, with an estimated ROI of 38.7% and a bullish sentiment.
The forecast indicates bullish potential from 2030 onward, with the average price rising to $17.08 by 2030 and up to $66.37 by 2050, and ROI up to 439.2%. These figures are estimates and not guarantees.
The max forecast shows $80.74 by 2040 and $152.66 by 2050, with intermediate years also projecting higher levels. A $50 level is within the projected ranges in the forecast.
The 30-day range is $9.51 to $15.93, with current price at $12.31.
Current price is $12.31 and market cap is $334.65M.
Carlsmed, Inc. Community Discussion
0Share your Carlsmed, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.